175 related articles for article (PubMed ID: 32253779)
1. Sarcopenia as a Predictor of Survival Among Patients With Organ Metastatic Cervical Cancer.
Yoshikawa N; Shirakawa A; Yoshida K; Tamauchi S; Suzuki S; Kikkawa F; Kajiyama H
Nutr Clin Pract; 2020 Dec; 35(6):1041-1046. PubMed ID: 32253779
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy.
Kise S; Arakaki Y; Kudaka W; Ariga T; Kinjo N; Kohatu H; Aoki Y
Anticancer Res; 2022 Oct; 42(10):4887-4893. PubMed ID: 36191992
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy.
Matsuoka H; Nakamura K; Matsubara Y; Ida N; Nishida T; Ogawa C; Katsi K; Kanazawa S; Masuyama H
Anticancer Res; 2019 Feb; 39(2):933-939. PubMed ID: 30711978
[TBL] [Abstract][Full Text] [Related]
4. Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study.
Ueki H; Hara T; Okamura Y; Bando Y; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
Investig Clin Urol; 2022 Jul; 63(4):415-424. PubMed ID: 35796138
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
6. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
[TBL] [Abstract][Full Text] [Related]
7. Measuring sarcopenia on pre-operative CT in older adults undergoing emergency laparotomy: a comparison of three different calculations.
Simpson G; Manu N; Magee C; Wilson J; Moug S; Vimalachandran D
Int J Colorectal Dis; 2020 Jun; 35(6):1095-1102. PubMed ID: 32215679
[TBL] [Abstract][Full Text] [Related]
8. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia.
Pigneur F; Di Palma M; Raynard B; Guibal A; Cohen F; Daidj N; Aziza R; El Hajjam M; Louis G; Goldwasser F; Deluche E
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1613-1620. PubMed ID: 37203274
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy.
Ozawa Y; Nakano T; Taniyama Y; Sakurai T; Onodera Y; Kamiya K; Hikage M; Sato C; Takaya K; Konno T; Unno M; Kamei T
Esophagus; 2019 Oct; 16(4):345-351. PubMed ID: 30980203
[TBL] [Abstract][Full Text] [Related]
10. A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy.
Saitoh-Maeda Y; Kawahara T; Miyoshi Y; Tsutsumi S; Takamoto D; Shimokihara K; Hayashi Y; Mochizuki T; Ohtaka M; Nakamura M; Hattori Y; Teranishi JI; Yumura Y; Osaka K; Ito H; Makiyama K; Nakaigawa N; Yao M; Uemura H
BMC Urol; 2017 Sep; 17(1):87. PubMed ID: 28923108
[TBL] [Abstract][Full Text] [Related]
11. The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?
Hahn F; Müller L; Stöhr F; Mähringer-Kunz A; Schotten S; Düber C; Bartsch F; Lang H; Galle PR; Weinmann A; Kloeckner R
Liver Int; 2019 Jul; 39(7):1307-1314. PubMed ID: 31070868
[TBL] [Abstract][Full Text] [Related]
12. A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma.
Noguchi G; Kawahara T; Kobayashi K; Tsutsumi S; Ohtake S; Osaka K; Umemoto S; Nakaigawa N; Uemura H; Kishida T; Yao M
PLoS One; 2020; 15(1):e0226581. PubMed ID: 31895931
[TBL] [Abstract][Full Text] [Related]
13. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
[TBL] [Abstract][Full Text] [Related]
14. A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.
Kasahara R; Kawahara T; Ohtake S; Saitoh Y; Tsutsumi S; Teranishi JI; Miyoshi Y; Nakaigawa N; Yao M; Kobayashi K; Uemura H
Biomed Res Int; 2017; 2017():7981549. PubMed ID: 28497065
[No Abstract] [Full Text] [Related]
15. Prognostic Impact of a Nutritional Index Including Muscle Volume in Stage 4 Colorectal Cancer.
Nagata T; Nakase Y; Nakamura K; Sougawa A; Mochiduki S; Kitai S; Inaba S
In Vivo; 2016 11-12; 30(6):885-891. PubMed ID: 27815476
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia as a prognostic factor in patients with recurrent pancreatic cancer: a retrospective study.
Sakamoto T; Yagyu T; Uchinaka E; Miyatani K; Hanaki T; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Honjo S; Fujiwara Y
World J Surg Oncol; 2020 Aug; 18(1):221. PubMed ID: 32828127
[TBL] [Abstract][Full Text] [Related]
17. Low psoas muscle index as an unfavorable factor in children with end-stage liver disease undergoing liver transplantation.
Jitwongwai S; Lertudomphonwanit C; Junhasavasdikul T; Fuangfa P; Tanpowpong P; Gesprasert G; Treepongkaruna S
Pediatr Transplant; 2021 Aug; 25(5):e13996. PubMed ID: 33734542
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Psoas Muscle Mass Index in Patients With Non‒ST-Segment‒Elevation Myocardial Infarction: A Prospective Observational Study.
Matsumoto H; Matsumura K; Yamamoto Y; Fujii K; Tsujimoto S; Otagaki M; Morishita S; Hashimoto K; Shibutani H; Sugiura T; Shiojima I
J Am Heart Assoc; 2020 Oct; 9(19):e017315. PubMed ID: 32975168
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
Kiyotoki T; Nakamura K; Haraga J; Omichi C; Ida N; Saijo M; Nishida T; Kusumoto T; Masuyama H
Int J Gynecol Cancer; 2018 Jan; 28(1):168-175. PubMed ID: 29040185
[TBL] [Abstract][Full Text] [Related]
20. Decreases in the Psoas Muscle Index Correlate More Strongly with Survival than Other Prognostic Markers in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Plus Esophagectomy.
Kawakita Y; Motoyama S; Sato Y; Wakita A; Nagaki Y; Imai K; Minamiya Y
World J Surg; 2020 May; 44(5):1559-1568. PubMed ID: 31907570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
